3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
3
Status
Completed
2
Recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Genitourinary
3
Gastrointestinal
1
Breast
1
Conditions
Prostatic Neoplasms
3
Urinary Bladder Neoplasms
1
Prostate Cancer Cured
1
Neoplasms
1
Kidney Neoplasms
1
Frailty
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Breast Neoplasms
1
Interventions
Docetaxel
292
Prednisone
240
enzalutamide
193
Leuprolide
185
Radiotherapy
179
Abiraterone Acetate
169
Magnetic Resonance Spectroscopy
163
bicalutamide
141
Goserelin
138
Androgen Antagonists
121
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
108
Radiosurgery
108
apalutamide
92
gallium 68 PSMA-11
81
abiraterone
81
Specimen Handling
73
darolutamide
65
Surveys and Questionnaires
64
Gonadotropin-Releasing Hormone
63
Triptorelin Pamoate
58
Radiation
57
Biopsy
57
Brachytherapy
54
cabazitaxel
52
Standard of Care
51
Radiotherapy, Intensity-Modulated
51
Zoledronic Acid
50
pembrolizumab
49
luprolide acetate gel depot
49
Flutamide
47
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Geriatric Assessment
×
Genitourinary
×
Clear all
NCT06125145
2025-12-05
GAP
University of California, Davis
Phase NA
Completed
30 enrolled
NCT05582772
2025-07-03
TOPCOP3
University Health Network, Toronto
Phase NA
Recruiting
168 enrolled
NCT02876237
2018-05-31
PROGERAD
Institut Cancerologie de l'Ouest
Phase NA
Completed
230 enrolled